In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
News|Articles|September 3, 2026
AAP Issues 2026-2027 Guidance on RSV and COVID-19 Immunization
Author(s)Kennedy Ferruggia, Associate Editor
Fact checked by: Ron Panarotti
Pediatric and obstetric groups expand high-risk criteria and extend vaccination windows as federal vaccine guidance remains unsettled.
Advertisement
Advertisement
With the CDC's Advisory Committee on Immunization Practices sidelined by legal challenges and reduced federal recommendations, professional societies have stepped in to fill the gap ahead of the 2026-2027 respiratory virus season. The American Academy of Pediatrics (AAP) published updated policy statements on respiratory syncytial virus (RSV) and COVID-19 prevention on September 2, 2026, following its earlier influenza guidance, whereas the American College of Obstetricians and Gynecologists (ACOG) released coordinated recommendations the same day for pregnant and postpartum patients.1-3
Related to this article
The project maps how flu and HIV proteins enter cells, with the aim of developing longer-lasting vaccines.
VAX-31 met all primary end points against PCV20 and PCV21 in the pivotal phase 3 OPUS-1 trial.
REDEFINE 1 analyses presented at The Menopause Society 2026 meeting found mean weight loss of 23.1% to 26.7% across pre-, peri-, and postmenopausal women.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Sea buckthorn is a commonly used herbal for respiratory health—US pharmacists are knowledgeable in educating patients on herbals, especially during the cold season.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Advertisement
Advertisement